- Home
- BANL vs CRIS Comparison
BANL vs CRIS Comparison
Compare BANL & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BANL
- CRIS
- Stock Information
- Founded
- BANL 2015
- CRIS 2000
- Country
- BANL Malaysia
- CRIS United States
- Employees
- BANL N/A
- CRIS N/A
- Industry
- BANL Oil Refining/Marketing
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BANL Energy
- CRIS Health Care
- Exchange
- BANL Nasdaq
- CRIS Nasdaq
- Market Cap
- BANL 25.3M
- CRIS 21.3M
- IPO Year
- BANL 2023
- CRIS 2000
- Fundamental
- Price
- BANL $0.82
- CRIS $2.16
- Analyst Decision
- BANL
- CRIS Strong Buy
- Analyst Count
- BANL 0
- CRIS 2
- Target Price
- BANL N/A
- CRIS $16.50
- AVG Volume (30 Days)
- BANL 1.6M
- CRIS 75.0K
- Earning Date
- BANL 04-16-2025
- CRIS 07-31-2025
- Dividend Yield
- BANL N/A
- CRIS N/A
- EPS Growth
- BANL N/A
- CRIS N/A
- EPS
- BANL N/A
- CRIS N/A
- Revenue
- BANL $592,517,545.00
- CRIS $11,202,000.00
- Revenue This Year
- BANL N/A
- CRIS N/A
- Revenue Next Year
- BANL N/A
- CRIS $10.67
- P/E Ratio
- BANL N/A
- CRIS N/A
- Revenue Growth
- BANL 35.93
- CRIS 14.17
- 52 Week Low
- BANL $0.55
- CRIS $1.02
- 52 Week High
- BANL $1.35
- CRIS $8.42
- Technical
- Relative Strength Index (RSI)
- BANL 46.59
- CRIS 45.09
- Support Level
- BANL $0.76
- CRIS $2.40
- Resistance Level
- BANL $1.00
- CRIS $2.57
- Average True Range (ATR)
- BANL 0.11
- CRIS 0.23
- MACD
- BANL 0.01
- CRIS -0.04
- Stochastic Oscillator
- BANL 53.26
- CRIS 0.00
About BANL CBL International Limited
CBL International Ltd is a marine fuel logistics company that provides a one-stop solution for vessel refueling. In the bunkering industry, it is referred to as a bunkering facilitator. It facilitates vessel refueling between ship operators and local physical distributors/traders by purchasing marine fuel, including fossil fuel and alternative fuel, from its suppliers and arranging for the suppliers to deliver the fuel to the customers. The company's customer base comprises container liners, bulk carriers, and tankers. Geographically, the company generates a majority of its revenue from China, followed by Hong Kong, Malaysia, Singapore, South Korea, and other regions.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.